Aethlon Medical, Inc.
(NASDAQ : AEMD)

( )
AEMD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 0.45%90.000.8%$461.39m
MDTMedtronic Plc -0.01%119.230.6%$441.08m
ISRGIntuitive Surgical, Inc. 0.44%570.002.4%$437.36m
DHRDanaher Corp. -0.69%161.130.7%$347.81m
TMOThermo Fisher Scientific, Inc. 1.09%334.531.0%$318.08m
BSXBoston Scientific Corp. -1.33%42.641.1%$317.59m
BDXBecton, Dickinson & Co. 0.06%279.751.1%$315.85m
SYKStryker Corp. -0.08%214.601.3%$287.36m
EWEdwards Lifesciences Corp. 1.18%231.671.2%$278.53m
BAXBaxter International, Inc. -0.03%90.531.8%$248.22m
ALGNAlign Technology, Inc. 1.99%266.106.4%$216.12m
ABMDABIOMED, Inc. -0.84%181.453.3%$198.79m
DXCMDexCom, Inc. 0.66%237.008.3%$180.85m
IDXXIDEXX Laboratories, Inc. 0.00%277.313.7%$130.06m
ZBHZimmer Biomet Holdings, Inc. 0.19%148.081.7%$116.86m

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.